Results 71 to 80 of about 226,373 (256)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

Thoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

Successful Treatment of Adenoid Cystic Carcinoma with the Application of a High-Dose Stereotactic Body Radiotherapy Boost

Case Reports in Oncology, 2021
Background: Adenoid cystic carcinoma (ACC) should be treated with a surgical procedure. Unfortunately, in some cases, such procedures are impossible to perform.
Paweł Polanowski, Dorota Księżniak-Baran, Aleksandra Grządziel, Agnieszka Pietruszka, Ewa Chmielik, Bolesław Pilecki, Natalia Amrogowicz, Karolina Gajda, Krzysztof Składowski   +8 more
doaj   +1 more source

Stereotactic body radiotherapy in the era of radiotherapy with immunotherapy [PDF]

Journal of Thoracic Disease, 2016
The spectrum of clinical use of stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR) has broaden, which has drawn much attention beyond radiation oncologists (1). Immunology and immunotherapy has been considered to provide curative potential for cancer therapy by key opinion leaders globally in recent years (2).
Xiaolin, Ge, Hongcheng, Zhu, Wangshu, Dai, Xinchen, Sun   +3 more
openaire   +2 more sources

Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single‐Institution Cohort Study

Head &Neck, EarlyView.
ABSTRACT Background Adenoid cystic carcinoma (ACC) is a rare malignancy with a propensity for perineural invasion and hematogenous spread. Central nervous system (CNS) involvement is uncommon, and detailed clinical and genomic data on this aspect of the disease remain limited.
Omar Elghawy, Jack Stylli, Martin Kurian, Eitan Halper‐Stromberg, Aditi Singh, Christopher D'Avella, Lee Hartner, Roger B. Cohen   +7 more
wiley   +1 more source

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

Frontiers in Oncology
IntroductionProstate cancer is the fourth most commonly diagnosed cancer among men worldwide. Various tools are used to manage disease such as conventional radiotherapy.
Youssef Slama, Gilles Baumont, Angelique Arcambal, Mickael Begue, Olivier Maillot, Rima Sayah, Romain Castanet, Raoul Caboche, Pedro Liberati, Hakim Slaoui, Medi Bouaziz, Olivier Borson, Nam P. Nguyen, Fabien Dutheil   +13 more
doaj   +1 more source

Radiation techniques for acromegaly

Radiation Oncology, 2011
Radiotherapy (RT) remains an effective treatment in patients with acromegaly refractory to medical and/or surgical interventions, with durable tumor control and biochemical remission; however, there are still concerns about delayed biochemical effect and
Minniti Giuseppe, Scaringi Claudia, Enrici Riccardo   +2 more
doaj   +1 more source

Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. [PDF]

PLoS ONE, 2014
Stereotactic ablative radiotherapy is being increasingly adopted in the treatment of lung tumors. The use of proton beam therapy can further reduce dose to normal structures.
Benjamin Mou, Chris J Beltran, Sean S Park, Kenneth R Olivier, Keith M Furutani   +4 more
doaj   +1 more source

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients

Pathology and Oncology Research, 2022
Cutaneous melanoma is the third most common type of skin cancer in the world. The incidence of melanoma is increasing in most countries, however, mortality seems to be slowly decreasing.
Mihály Kispál, Levente Zsolt Jánváry, Tímea Balatoni, Stelczer Gábor, Imre Fedorcsák, Bőcs Katalin, István Kenessey, Gabriella Liszkay   +7 more
doaj   +1 more source

Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma

, 2004
BACKGROUND AND PURPOSE: To report on the efficacy and follow-up of 23 patients with primary optic nerve sheath meningioma (ONSM) with fractionated stereotactic conformal radiotherapy (SCRT). PATIENTS AND METHODS: Between 1996 and 2003, 23 patients ( = 23
Baumert, B. G., Studer, G., Landau, K., Mirimanoff, R. O., Lambin, P., Villa, S., Arruga, J., Pica, A., Davis, J. B., Ducrey, N.   +9 more
core   +1 more source